Development of an Aid to Melanoma Detection Using Artificial Intelligence Algorithms Based on Images From the VECTRA 3D System.
NCT06999499 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000
Last updated 2025-11-18
Summary
The background to this research is that frequent medical screening of the general population for melanoma is not feasible. The real challenge of this project is to develop an automatic process for detecting any potential melanoma. To this end, the project aims to design an algorithm to build a novel diagnostic aid that makes use of the similarity and disparity of pigmented lesions in the same patient. To achieve this, we need to obtain and structure a large database of images grouping all pigmented lesions per patient according to their similarities as perceived by dermatologists.
Conditions
- Naevi
Interventions
- OTHER
-
Scanner of the whole body using the VECTRA 3D
Whole body image acquisition using the VECTRA 3D Whole Body 360 Imaging System to detect potential melanoma
Sponsors & Collaborators
-
Assistance Publique Hopitaux De Marseille
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-03-01
- Primary Completion
- 2028-03-01
- Completion
- 2028-06-01
Countries
- France
Study Locations
More Related Trials
-
Diagnostic Precision of the AI Tool Dermalyzer to Identify Malignant Melanomas in Subjects Seeking Primary Care for Melanoma-suspected Cutaneous Lesions
NCT05172232 ·Status: COMPLETED
-
AI-Augmented Skin Cancer Diagnosis in Teledermatoscopy
NCT06080711 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Feasibility and Functionality of fPAM Imaging in Melanoma
NCT00776945 ·Status: TERMINATED
-
Improving Skin Cancer Management With Artificial Intelligence (04.17 SMARTI)
NCT04040114 ·Status: COMPLETED ·Phase: NA
-
Artificial Intelligence-assisted Evaluation of Pigmented Skin Lesions
NCT03362138 ·Status: UNKNOWN
-
AI Augmented Training for Skin Specialists
NCT04758988 ·Status: COMPLETED ·Phase: NA
-
How Consistent is the Output of DERM, When Used to Assess Images of Potentially Cancerous Skin Lesions.
NCT06654999 ·Status: COMPLETED
-
Artificial Intelligent Decision Support for Skin Cancer Diagnostics in Primary Care
NCT06932172 ·Status: RECRUITING ·Phase: NA
-
Melanoma Surveillance Photography (MSP) to Improve Early Detection of Melanoma in Ultra-high and High Risk Patients
NCT04385732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)
NCT02470273 ·Status: COMPLETED
-
Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi
NCT01118832 ·Status: COMPLETED
-
Imaging Methods for the Diagnosis of Non-melanoma Skin Cancer and Its Precursors
NCT05842421 ·Status: COMPLETED ·Phase: NA
-
Melanoma Image Analysis Algorithm (MIAA) Validation Study
NCT02612168 ·Status: COMPLETED ·Phase: NA
-
ARTIficial Intelligence-based Smartphone Application for Skin Cancer Detection
NCT05246163 ·Status: RECRUITING
-
Nuclear and Near-Infrared (NIR) Imaging in Melanoma
NCT01295931 ·Status: COMPLETED ·Phase: PHASE1
-
Fast Track Diagnosis of Skin Cancer by Advanced Imaging
NCT04229277 ·Status: COMPLETED ·Phase: NA
-
Elucid Labs AIDA™ - Labelled Image Acquisition Protocol
NCT03621462 ·Status: UNKNOWN ·Phase: NA
-
Artificial Intelligence Augmented Training in Skin Cancer Diagnostics for General Practitioners
NCT04576416 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging
NCT02056522 ·Status: COMPLETED
-
iToBoS: Clinical Data Acquisition Study
NCT05075356 ·Status: UNKNOWN ·Phase: NA
-
Use of Fiber-optic Probe for Non-invasive Diagnosis of Melanoma and Assessment of Impact of Ultraviolet (UV) Exposure on Skin
NCT01085396 ·Status: TERMINATED
-
Video-Tumorboard PLUS
NCT06980740 ·Status: RECRUITING
-
Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases
NCT02336763 ·Status: TERMINATED ·Phase: NA
-
MoleGazer Development Feasibility Study
NCT05015816 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Precision Medicine for L/GCMN and Melanoma 1
NCT06608420 ·Status: RECRUITING